Glucagon-like peptide 2 counteracts the mucosal damage and the neuropathy induced by chronic treatment with cisplatin in the mouse gastric fundus

Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity

(2015) Vanesa Stojanovska et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Gut hormones in the treatment of short-bowel syndrome and intestinal failure

(2015) Palle B. Jeppesen   Current Opinion in Endocrinology Diabetes and Obesity

New approaches to the treatments of short bowel syndrome-associated intestinal failure

(2014) Palle B. Jeppesen   CURRENT OPINION IN GASTROENTEROLOGY

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Influence of obestatin on the gastric longitudinal smooth muscle from mice: mechanical and electrophysiological studies

(2013) Roberta Squecco et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet

(2013) Sara Baldassano et al.   JOURNAL OF ENDOCRINOLOGY

Role of neuronal and inducible nitric oxide synthases in the guinea pig ileum myenteric plexus duringin vitroischemia and reperfusion

(2013) C. Giaroni et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Glucagon-like peptides 1 and 2 in health and disease: A review

(2013) Chinmay S. Marathe et al.   PEPTIDES

Effects of oxaliplatin on mouse myenteric neurons and colonic motility

(2013) Linah Wafai et al.   Frontiers in Neuroscience

Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer

(2012) Shivangi Trivedi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Chrysin abrogates cisplatin-induced oxidative stress, p53 expression, goblet cell disintegration and apoptotic responses in the jejunum of Wistar rats

(2012) Rehan Khan et al.   BRITISH JOURNAL OF NUTRITION

Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine

(2012) Hannelouise Kissow et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The “cryptic” mechanism of action of glucagon-like peptide-2

(2011) Katherine J. Rowland et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease

(2011) Pamela J Hornby et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

GLP-2 receptor expression in excitatory and inhibitory enteric neurons and its role in mouse duodenum contractility

(2011) L. Cinci et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Enteric neuropathy evoked by repeated cisplatin in the rat

(2011) G. Vera et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Relaxin counteracts the altered gastric motility of dystrophic (mdx) mice: functional and immunohistochemical evidence for the involvement of nitric oxide

(2010) M. G. Vannucchi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

The Intestinotrophic Peptide, GLP-2, Counteracts the Gastrointestinal Atrophy in Mice Induced by the Epidermal Growth Factor Receptor Inhibitor, Erlotinib, and Cisplatin

(2010) Andreas Rosén Rasmussen et al.   DIGESTIVE DISEASES AND SCIENCES

Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica

(2010) P. A. Cabezos et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Acute and long-term gastrointestinal consequences of chemotherapy

(2009) Frédéric Di Fiore et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Contribution of endogenous nitrergic and peptidergic influences to the altered neurally-induced gastric contractile responses in strips from dystrophic (mdx) mice

(2009) Rachele Garella et al.   REGULATORY PEPTIDES

Radiological study of gastrointestinal motor activity after acute cisplatin in the rat. Temporal relationship with pica

(2008) Pablo Antonio Cabezos et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance

(2008) E L Leung et al.   BRITISH JOURNAL OF CANCER